Clinical and experimental advances in treatment of visceral leishmaniasis

被引:175
作者
Murray, HW [1 ]
机构
[1] Cornell Univ, Weill Med Coll, Dept Med, New York, NY 10021 USA
关键词
D O I
10.1128/AAC.45.8.2185-2197.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:2185 / 2197
页数:13
相关论文
共 211 条
[1]  
Ahuja SS, 1999, J IMMUNOL, V163, P3890
[2]   Efficacy of the triazole SCH 56592 against Leishmania amazonensis and Leishmania donovani in experimental murine cutaneous and visceral leishmaniases [J].
Al-Abdely, HM ;
Graybill, JR ;
Loebenberg, D ;
Melby, PC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (12) :2910-2914
[3]   Efficacies of KY62 against Leishmania amazonensis and Leishmania donovani in experimental murine cutaneous leishmaniasis and visceral leishmaniasis [J].
Al-Abdely, HM ;
Graybill, JR ;
Bocanegra, R ;
Najvar, L ;
Montalbo, E ;
Regen, SL ;
Melby, PC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (10) :2542-2548
[4]  
Alexander J, 2000, EUR J IMMUNOL, V30, P2935, DOI 10.1002/1521-4141(200010)30:10&lt
[5]  
2935::AID-IMMU2935&gt
[6]  
3.0.CO
[7]  
2-Q
[8]   Randomized, double-blind study of stibogluconate plus human granulocyte macrophage colony-stimulating factor versus stibogluconate alone in the treatment of cutaneous leishmaniasis [J].
Almeida, R ;
D'Oliveira, A ;
Machado, P ;
Bacellar, O ;
Ko, AI ;
de Jesus, AR ;
Mobashery, N ;
Santos, JB ;
Carvalho, EM .
JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (05) :1735-1737
[9]   Leishmania and human immunodeficiency virus coinfection: The first 10 years [J].
Alvar, J ;
Canavate, C ;
GutierrezSolar, B ;
Jimenez, M ;
Laguna, F ;
LopezVelez, R ;
Molina, R ;
Moreno, J .
CLINICAL MICROBIOLOGY REVIEWS, 1997, 10 (02) :298-+
[10]   THERAPY OF LEISHMANIASIS - SUPERIOR EFFICACIES OF LIPOSOME-ENCAPSULATED DRUGS [J].
ALVING, CR ;
STECK, EA ;
CHAPMAN, WL ;
WAITS, VB ;
HENDRICKS, LD ;
SWARTZ, GM ;
HANSON, WL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1978, 75 (06) :2959-2963